Published in J Perinat Med on March 01, 2010
Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care (2011) 0.91
Association of retinol binding protein 4 with risk of gestational diabetes. Diabetes Res Clin Pract (2012) 0.80
Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature (2006) 15.48
Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser (2003) 14.60
Abdominal obesity and metabolic syndrome. Nature (2006) 14.20
CRITERIA FOR THE ORAL GLUCOSE TOLERANCE TEST IN PREGNANCY. Diabetes (1964) 10.12
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature (2005) 10.10
Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol (1982) 9.60
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med (2006) 9.53
Adipocytes as regulators of energy balance and glucose homeostasis. Nature (2006) 9.52
Obesity and the regulation of energy balance. Cell (2001) 9.48
Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care (2002) 9.08
Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation (2000) 6.96
Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care (1998) 6.21
Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. N Engl J Med (1999) 5.05
Gestational diabetes mellitus. J Clin Invest (2005) 4.60
Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation (2002) 3.81
Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med (2004) 3.41
Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab (2004) 2.74
Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab (2007) 2.58
Birth weight as a predictor of brachial plexus injury. Obstet Gynecol (1997) 2.21
Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab (2001) 2.11
Prevention of diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser (1994) 1.96
[A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000]. Rev Med Chil (2004) 1.94
Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab (2007) 1.85
Maternal age and screening for gestational diabetes: a population-based study. Obstet Gynecol (1989) 1.84
Retinol to retinol-binding protein (RBP) is low in obese adults due to elevated apo-RBP. Exp Biol Med (Maywood) (2008) 1.77
Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab (2007) 1.77
Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr (2003) 1.70
Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care (1993) 1.54
Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab (2006) 1.45
Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes (1999) 1.43
Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes (1995) 1.43
Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia (2007) 1.41
Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab (2001) 1.41
Adiponectin in human cord blood: relation to fetal birth weight and gender. J Clin Endocrinol Metab (2003) 1.38
Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J Clin Endocrinol Metab (2007) 1.37
Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes (1999) 1.35
Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia. Hum Genet (2006) 1.32
A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia (2000) 1.31
Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. J Clin Endocrinol Metab (2007) 1.24
Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes Obes Metab (2005) 1.21
Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol (1991) 1.18
Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits. Mol Genet Metab (2006) 1.15
Gestational diabetes: predictors of subsequent disordered glucose metabolism. Am J Obstet Gynecol (1993) 1.11
RBP4, an unexpected adipokine. Nat Med (2006) 1.09
Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy. Am J Obstet Gynecol (1989) 1.09
Abnormal glucose screening tests in pregnancy: a risk factor for fetal macrosomia. Obstet Gynecol (1987) 1.09
Increased serum retinol-binding protein 4 concentrations in women with gestational diabetes mellitus. Reprod Sci (2007) 1.04
High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab (2008) 1.04
Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss. Obesity (Silver Spring) (2008) 1.03
Determining the source of fetal adiponectin. J Reprod Med (2007) 1.02
Genetic association study of adiponectin polymorphisms with risk of Type 2 diabetes mellitus in Korean population. Diabet Med (2005) 1.01
Retinol-binding protein 4 in twins: regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action. Diabetes (2008) 0.98
Clinical utility and approaches for estimating insulin sensitivity in pregnancy. Semin Perinatol (2002) 0.98
Adiponectin in severe preeclampsia. J Perinat Med (2007) 0.97
Retinol-binding protein 4, insulin resistance, and type 2 diabetes. N Engl J Med (2006) 0.97
Resistin in amniotic fluid and its association with intra-amniotic infection and inflammation. J Matern Fetal Neonatal Med (2008) 0.97
Maternal serum adiponectin levels during human pregnancy. J Perinatol (2007) 0.95
The association between glucose challenge test, obesity and pregnancy outcome in 6390 non-diabetic women. J Matern Fetal Neonatal Med (2005) 0.95
Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes. Diabetologia (2008) 0.95
Vitamin A and retinol-binding protein metabolism during fetal development in the rat. Am J Physiol (1977) 0.95
Circulating retinol-binding protein 4 and subclinical cardiovascular disease in the elderly. Diabetes Care (2008) 0.95
Maternal serum adiponectin multimers in gestational diabetes. J Perinat Med (2009) 0.94
Cord blood adiponectin in large-for-gestational age newborns. Am J Obstet Gynecol (2005) 0.94
Retinol-binding protein-4 in experimental and clinical metabolic disease. Expert Rev Mol Diagn (2008) 0.93
Maternal serum adiponectin multimers in preeclampsia. J Perinat Med (2009) 0.92
Subclinical abnormalities of glucose metabolism in subjects with previous gestational diabetes. Am J Obstet Gynecol (1986) 0.92
Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism. Eur J Endocrinol (2007) 0.92
Plasma adiponectin concentrations in non-pregnant, normal and overweight pregnant women. J Perinat Med (2007) 0.92
Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight. J Perinat Med (2009) 0.92
High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population. Diabetologia (1996) 0.91
Retinol binding protein 4: an adipokine associated with intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med (2010) 0.91
Resistin: a hormone which induces insulin resistance is increased in normal pregnancy. J Perinat Med (2007) 0.90
Metabolism: A is for adipokine. Nature (2005) 0.90
Adiponectin multimers in maternal plasma. J Matern Fetal Neonatal Med (2008) 0.89
Adiponectin and human pregnancy. Curr Diab Rep (2005) 0.89
Adiponectin in amniotic fluid in normal pregnancy, spontaneous labor at term, and preterm labor: a novel association with intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med (2010) 0.89
Elevated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1). Gynecol Endocrinol (2008) 0.89
Gestational diabetes mellitus. N Engl J Med (1986) 0.89
Decreased expression of the GLUT4 glucose transporter protein in adipose tissue during pregnancy. Horm Metab Res (1995) 0.88
Retinol binding protein 4--a novel association with early-onset preeclampsia. J Perinat Med (2010) 0.87
Regulation of retinol binding protein 4 production in primary human adipocytes by adiponectin, troglitazone and TNF-alpha. Diabetologia (2007) 0.87
Autoimmune gestational diabetes mellitus: a distinct clinical entity? Diabetes Metab Res Rev (2001) 0.87
Abdominal visceral fat reduction is associated with favorable changes of serum retinol binding protein-4 in nondiabetic subjects. Endocr J (2008) 0.86
Maternal visfatin concentration in normal pregnancy. J Perinat Med (2009) 0.86
Adiponectin and leptin concentrations in dichorionic twins with discordant and concordant growth. J Clin Endocrinol Metab (2008) 0.84
Maternal plasma visfatin in preterm labor. J Matern Fetal Neonatal Med (2009) 0.83
Dysregulation of maternal serum adiponectin in preterm labor. J Matern Fetal Neonatal Med (2009) 0.83
Maternal serum adiponectin multimers in patients with a small-for-gestational-age newborn. J Perinat Med (2009) 0.82
Low circulating maternal adiponectin in patients with pyelonephritis: adiponectin at the crossroads of pregnancy and infection. J Perinat Med (2010) 0.81
Retinol-binding protein 4 responses during an oral glucose tolerance testing in women with gestational diabetes mellitus. Clin Chim Acta (2008) 0.81
The effect of minor degrees of glucose intolerance on the incidence of neonatal macrosomia. Obstet Gynecol (1992) 0.80
Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA? J Matern Fetal Neonatal Med (2010) 0.79
From the NIH: Successful diet and exercise therapy is conducted in Vermont for "diabesity". JAMA (1980) 0.79
Elevated level of serum retinol-binding protein 4 in pregnancy-induced hypertension. J Obstet Gynaecol Res (2009) 0.79
Human fetal adiponectin and retinol-binding protein (RBP)-4 levels in relation to birth weight and maternal obesity. Exp Clin Endocrinol Diabetes (2008) 0.79
Gestational diabetes: insulin requirements in pregnancy. Am J Obstet Gynecol (1987) 0.79
Selective screening for gestational diabetes mellitus in adolescent pregnancies. Obstet Gynecol (1999) 0.78
Retinol-binding protein-4 is not strongly associated with insulin sensitivity in normal pregnancies. Eur J Endocrinol (2008) 0.78
Epidemiology and causes of preterm birth. Lancet (2008) 18.96
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06
A systems biology approach for pathway level analysis. Genome Res (2007) 6.95
Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med (2006) 6.21
A novel signaling pathway impact analysis. Bioinformatics (2008) 5.06
The role of inflammation and infection in preterm birth. Semin Reprod Med (2007) 3.57
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med (2012) 3.43
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med (2008) 3.39
Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One (2008) 3.01
Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol (2011) 2.95
Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet (2008) 2.90
Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol (2007) 2.78
Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med (2006) 2.59
Machine learning and its applications to biology. PLoS Comput Biol (2007) 2.57
Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol (2003) 2.55
Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev (2002) 2.42
The fetal inflammatory response syndrome. Clin Obstet Gynecol (2007) 2.36
The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome (2014) 2.24
Listeriosis in human pregnancy: a systematic review. J Perinat Med (2011) 2.20
The role of cervical cerclage in obstetric practice: can the patient who could benefit from this procedure be identified? Am J Obstet Gynecol (2006) 2.11
Diabetes prevalence and determinants in adults in China mainland from 2000 to 2010: a systematic review. Diabetes Res Clin Pract (2012) 2.07
Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev (2007) 2.01
The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol (2010) 1.99
Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med (2005) 1.99
Evolution of the mammalian placenta revealed by phylogenetic analysis. Proc Natl Acad Sci U S A (2006) 1.89
Genomics, biogeography, and the diversification of placental mammals. Proc Natl Acad Sci U S A (2007) 1.86
CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12. Prostate (2006) 1.86
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med (2009) 1.84
A sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med (2006) 1.82
Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol (2004) 1.81
Infection and prematurity and the role of preventive strategies. Semin Neonatol (2002) 1.78
Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery. J Matern Fetal Neonatal Med (2010) 1.77
Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am J Obstet Gynecol (2010) 1.77
Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. Am J Obstet Gynecol (2009) 1.77
Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes. Am J Obstet Gynecol (2010) 1.75
Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol (2010) 1.74
Human spontaneous labor without histologic chorioamnionitis is characterized by an acute inflammation gene expression signature. Am J Obstet Gynecol (2006) 1.73
Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol (2011) 1.69
Gene-centric genomewide association study via entropy. Genetics (2008) 1.68
Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol (2011) 1.65
Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol (2004) 1.64
A short cervix in women with preterm labor and intact membranes: a risk factor for microbial invasion of the amniotic cavity. Am J Obstet Gynecol (2005) 1.64
Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J Matern Fetal Neonatal Med (2007) 1.62
The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med (2008) 1.60
Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol (2004) 1.60
Intrauterine endotoxin administration leads to white matter diffusivity changes in newborn rabbits. J Child Neurol (2009) 1.58
Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol (2002) 1.58
Structural and functional comparison of mast cells in the pregnant versus nonpregnant human uterus. Am J Obstet Gynecol (2006) 1.54
The clinical significance of a positive Amnisure test in women with term labor with intact membranes. J Matern Fetal Neonatal Med (2009) 1.54
A systematic approach to the use of the multiplanar display in evaluation of abnormal vascular connections to the fetal heart using 4-dimensional ultrasonography. J Ultrasound Med (2007) 1.53
The ninety-fifth percentile for growth discordance predicts complications of twin pregnancy. Am J Obstet Gynecol (2002) 1.53
Analysis of microarray experiments of gene expression profiling. Am J Obstet Gynecol (2006) 1.53
Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol (2004) 1.51
Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol (2009) 1.50
The evolution of menstruation: a new model for genetic assimilation: explaining molecular origins of maternal responses to fetal invasiveness. Bioessays (2011) 1.50
The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J Matern Fetal Neonatal Med (2008) 1.50